Global Cancer Microbiome Supply, Demand and Key Producers, 2023-2029
The global Cancer Microbiome market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Cancer Microbiome demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cancer Microbiome, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cancer Microbiome that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cancer Microbiome total market, 2018-2029, (USD Million)
Global Cancer Microbiome total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Cancer Microbiome total market, key domestic companies and share, (USD Million)
Global Cancer Microbiome revenue by player and market share 2018-2023, (USD Million)
Global Cancer Microbiome total market by Type, CAGR, 2018-2029, (USD Million)
Global Cancer Microbiome total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Cancer Microbiome market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CD Genomics, Eurofins Scientific, Illumina, Prescient Medicine Holding, Micronoma, Novogene, Oxford Nanopore Technologies, Pacific Biosciences and Qiagen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cancer Microbiome market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Cancer Microbiome Market, By Region:
1. How big is the global Cancer Microbiome market?
2. What is the demand of the global Cancer Microbiome market?
3. What is the year over year growth of the global Cancer Microbiome market?
4. What is the total value of the global Cancer Microbiome market?
5. Who are the major players in the global Cancer Microbiome market?
6. What are the growth factors driving the market demand?
This report studies the global Cancer Microbiome demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cancer Microbiome, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cancer Microbiome that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cancer Microbiome total market, 2018-2029, (USD Million)
Global Cancer Microbiome total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Cancer Microbiome total market, key domestic companies and share, (USD Million)
Global Cancer Microbiome revenue by player and market share 2018-2023, (USD Million)
Global Cancer Microbiome total market by Type, CAGR, 2018-2029, (USD Million)
Global Cancer Microbiome total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Cancer Microbiome market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CD Genomics, Eurofins Scientific, Illumina, Prescient Medicine Holding, Micronoma, Novogene, Oxford Nanopore Technologies, Pacific Biosciences and Qiagen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cancer Microbiome market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Cancer Microbiome Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Next Generation Sequencing
- Polymerase Chain Reaction
- Hospitals
- Clinic
- Others
- CD Genomics
- Eurofins Scientific
- Illumina
- Prescient Medicine Holding
- Micronoma
- Novogene
- Oxford Nanopore Technologies
- Pacific Biosciences
- Qiagen
- Therma Fisher Scientific
1. How big is the global Cancer Microbiome market?
2. What is the demand of the global Cancer Microbiome market?
3. What is the year over year growth of the global Cancer Microbiome market?
4. What is the total value of the global Cancer Microbiome market?
5. Who are the major players in the global Cancer Microbiome market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Cancer Microbiome Introduction
1.2 World Cancer Microbiome Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Cancer Microbiome Total Market by Region (by Headquarter Location)
1.3.1 World Cancer Microbiome Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Cancer Microbiome Market Size (2018-2029)
1.3.3 China Cancer Microbiome Market Size (2018-2029)
1.3.4 Europe Cancer Microbiome Market Size (2018-2029)
1.3.5 Japan Cancer Microbiome Market Size (2018-2029)
1.3.6 South Korea Cancer Microbiome Market Size (2018-2029)
1.3.7 ASEAN Cancer Microbiome Market Size (2018-2029)
1.3.8 India Cancer Microbiome Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cancer Microbiome Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cancer Microbiome Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Cancer Microbiome Consumption Value (2018-2029)
2.2 World Cancer Microbiome Consumption Value by Region
2.2.1 World Cancer Microbiome Consumption Value by Region (2018-2023)
2.2.2 World Cancer Microbiome Consumption Value Forecast by Region (2024-2029)
2.3 United States Cancer Microbiome Consumption Value (2018-2029)
2.4 China Cancer Microbiome Consumption Value (2018-2029)
2.5 Europe Cancer Microbiome Consumption Value (2018-2029)
2.6 Japan Cancer Microbiome Consumption Value (2018-2029)
2.7 South Korea Cancer Microbiome Consumption Value (2018-2029)
2.8 ASEAN Cancer Microbiome Consumption Value (2018-2029)
2.9 India Cancer Microbiome Consumption Value (2018-2029)
3 WORLD CANCER MICROBIOME COMPANIES COMPETITIVE ANALYSIS
3.1 World Cancer Microbiome Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cancer Microbiome Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cancer Microbiome in 2022
3.2.3 Global Concentration Ratios (CR8) for Cancer Microbiome in 2022
3.3 Cancer Microbiome Company Evaluation Quadrant
3.4 Cancer Microbiome Market: Overall Company Footprint Analysis
3.4.1 Cancer Microbiome Market: Region Footprint
3.4.2 Cancer Microbiome Market: Company Product Type Footprint
3.4.3 Cancer Microbiome Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Cancer Microbiome Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cancer Microbiome Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Cancer Microbiome Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Cancer Microbiome Consumption Value Comparison
4.2.1 United States VS China: Cancer Microbiome Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Cancer Microbiome Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Cancer Microbiome Companies and Market Share, 2018-2023
4.3.1 United States Based Cancer Microbiome Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cancer Microbiome Revenue, (2018-2023)
4.4 China Based Companies Cancer Microbiome Revenue and Market Share, 2018-2023
4.4.1 China Based Cancer Microbiome Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cancer Microbiome Revenue, (2018-2023)
4.5 Rest of World Based Cancer Microbiome Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Cancer Microbiome Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Cancer Microbiome Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Cancer Microbiome Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Next Generation Sequencing
5.2.2 Polymerase Chain Reaction
5.3 Market Segment by Type
5.3.1 World Cancer Microbiome Market Size by Type (2018-2023)
5.3.2 World Cancer Microbiome Market Size by Type (2024-2029)
5.3.3 World Cancer Microbiome Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Cancer Microbiome Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospitals
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Cancer Microbiome Market Size by Application (2018-2023)
6.3.2 World Cancer Microbiome Market Size by Application (2024-2029)
6.3.3 World Cancer Microbiome Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 CD Genomics
7.1.1 CD Genomics Details
7.1.2 CD Genomics Major Business
7.1.3 CD Genomics Cancer Microbiome Product and Services
7.1.4 CD Genomics Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 CD Genomics Recent Developments/Updates
7.1.6 CD Genomics Competitive Strengths & Weaknesses
7.2 Eurofins Scientific
7.2.1 Eurofins Scientific Details
7.2.2 Eurofins Scientific Major Business
7.2.3 Eurofins Scientific Cancer Microbiome Product and Services
7.2.4 Eurofins Scientific Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Eurofins Scientific Recent Developments/Updates
7.2.6 Eurofins Scientific Competitive Strengths & Weaknesses
7.3 Illumina
7.3.1 Illumina Details
7.3.2 Illumina Major Business
7.3.3 Illumina Cancer Microbiome Product and Services
7.3.4 Illumina Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Illumina Recent Developments/Updates
7.3.6 Illumina Competitive Strengths & Weaknesses
7.4 Prescient Medicine Holding
7.4.1 Prescient Medicine Holding Details
7.4.2 Prescient Medicine Holding Major Business
7.4.3 Prescient Medicine Holding Cancer Microbiome Product and Services
7.4.4 Prescient Medicine Holding Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Prescient Medicine Holding Recent Developments/Updates
7.4.6 Prescient Medicine Holding Competitive Strengths & Weaknesses
7.5 Micronoma
7.5.1 Micronoma Details
7.5.2 Micronoma Major Business
7.5.3 Micronoma Cancer Microbiome Product and Services
7.5.4 Micronoma Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Micronoma Recent Developments/Updates
7.5.6 Micronoma Competitive Strengths & Weaknesses
7.6 Novogene
7.6.1 Novogene Details
7.6.2 Novogene Major Business
7.6.3 Novogene Cancer Microbiome Product and Services
7.6.4 Novogene Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Novogene Recent Developments/Updates
7.6.6 Novogene Competitive Strengths & Weaknesses
7.7 Oxford Nanopore Technologies
7.7.1 Oxford Nanopore Technologies Details
7.7.2 Oxford Nanopore Technologies Major Business
7.7.3 Oxford Nanopore Technologies Cancer Microbiome Product and Services
7.7.4 Oxford Nanopore Technologies Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Oxford Nanopore Technologies Recent Developments/Updates
7.7.6 Oxford Nanopore Technologies Competitive Strengths & Weaknesses
7.8 Pacific Biosciences
7.8.1 Pacific Biosciences Details
7.8.2 Pacific Biosciences Major Business
7.8.3 Pacific Biosciences Cancer Microbiome Product and Services
7.8.4 Pacific Biosciences Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Pacific Biosciences Recent Developments/Updates
7.8.6 Pacific Biosciences Competitive Strengths & Weaknesses
7.9 Qiagen
7.9.1 Qiagen Details
7.9.2 Qiagen Major Business
7.9.3 Qiagen Cancer Microbiome Product and Services
7.9.4 Qiagen Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Qiagen Recent Developments/Updates
7.9.6 Qiagen Competitive Strengths & Weaknesses
7.10 Therma Fisher Scientific
7.10.1 Therma Fisher Scientific Details
7.10.2 Therma Fisher Scientific Major Business
7.10.3 Therma Fisher Scientific Cancer Microbiome Product and Services
7.10.4 Therma Fisher Scientific Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Therma Fisher Scientific Recent Developments/Updates
7.10.6 Therma Fisher Scientific Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Cancer Microbiome Industry Chain
8.2 Cancer Microbiome Upstream Analysis
8.3 Cancer Microbiome Midstream Analysis
8.4 Cancer Microbiome Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Cancer Microbiome Introduction
1.2 World Cancer Microbiome Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Cancer Microbiome Total Market by Region (by Headquarter Location)
1.3.1 World Cancer Microbiome Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Cancer Microbiome Market Size (2018-2029)
1.3.3 China Cancer Microbiome Market Size (2018-2029)
1.3.4 Europe Cancer Microbiome Market Size (2018-2029)
1.3.5 Japan Cancer Microbiome Market Size (2018-2029)
1.3.6 South Korea Cancer Microbiome Market Size (2018-2029)
1.3.7 ASEAN Cancer Microbiome Market Size (2018-2029)
1.3.8 India Cancer Microbiome Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cancer Microbiome Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cancer Microbiome Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Cancer Microbiome Consumption Value (2018-2029)
2.2 World Cancer Microbiome Consumption Value by Region
2.2.1 World Cancer Microbiome Consumption Value by Region (2018-2023)
2.2.2 World Cancer Microbiome Consumption Value Forecast by Region (2024-2029)
2.3 United States Cancer Microbiome Consumption Value (2018-2029)
2.4 China Cancer Microbiome Consumption Value (2018-2029)
2.5 Europe Cancer Microbiome Consumption Value (2018-2029)
2.6 Japan Cancer Microbiome Consumption Value (2018-2029)
2.7 South Korea Cancer Microbiome Consumption Value (2018-2029)
2.8 ASEAN Cancer Microbiome Consumption Value (2018-2029)
2.9 India Cancer Microbiome Consumption Value (2018-2029)
3 WORLD CANCER MICROBIOME COMPANIES COMPETITIVE ANALYSIS
3.1 World Cancer Microbiome Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cancer Microbiome Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cancer Microbiome in 2022
3.2.3 Global Concentration Ratios (CR8) for Cancer Microbiome in 2022
3.3 Cancer Microbiome Company Evaluation Quadrant
3.4 Cancer Microbiome Market: Overall Company Footprint Analysis
3.4.1 Cancer Microbiome Market: Region Footprint
3.4.2 Cancer Microbiome Market: Company Product Type Footprint
3.4.3 Cancer Microbiome Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Cancer Microbiome Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cancer Microbiome Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Cancer Microbiome Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Cancer Microbiome Consumption Value Comparison
4.2.1 United States VS China: Cancer Microbiome Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Cancer Microbiome Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Cancer Microbiome Companies and Market Share, 2018-2023
4.3.1 United States Based Cancer Microbiome Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cancer Microbiome Revenue, (2018-2023)
4.4 China Based Companies Cancer Microbiome Revenue and Market Share, 2018-2023
4.4.1 China Based Cancer Microbiome Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cancer Microbiome Revenue, (2018-2023)
4.5 Rest of World Based Cancer Microbiome Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Cancer Microbiome Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Cancer Microbiome Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Cancer Microbiome Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Next Generation Sequencing
5.2.2 Polymerase Chain Reaction
5.3 Market Segment by Type
5.3.1 World Cancer Microbiome Market Size by Type (2018-2023)
5.3.2 World Cancer Microbiome Market Size by Type (2024-2029)
5.3.3 World Cancer Microbiome Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Cancer Microbiome Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospitals
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Cancer Microbiome Market Size by Application (2018-2023)
6.3.2 World Cancer Microbiome Market Size by Application (2024-2029)
6.3.3 World Cancer Microbiome Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 CD Genomics
7.1.1 CD Genomics Details
7.1.2 CD Genomics Major Business
7.1.3 CD Genomics Cancer Microbiome Product and Services
7.1.4 CD Genomics Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 CD Genomics Recent Developments/Updates
7.1.6 CD Genomics Competitive Strengths & Weaknesses
7.2 Eurofins Scientific
7.2.1 Eurofins Scientific Details
7.2.2 Eurofins Scientific Major Business
7.2.3 Eurofins Scientific Cancer Microbiome Product and Services
7.2.4 Eurofins Scientific Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Eurofins Scientific Recent Developments/Updates
7.2.6 Eurofins Scientific Competitive Strengths & Weaknesses
7.3 Illumina
7.3.1 Illumina Details
7.3.2 Illumina Major Business
7.3.3 Illumina Cancer Microbiome Product and Services
7.3.4 Illumina Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Illumina Recent Developments/Updates
7.3.6 Illumina Competitive Strengths & Weaknesses
7.4 Prescient Medicine Holding
7.4.1 Prescient Medicine Holding Details
7.4.2 Prescient Medicine Holding Major Business
7.4.3 Prescient Medicine Holding Cancer Microbiome Product and Services
7.4.4 Prescient Medicine Holding Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Prescient Medicine Holding Recent Developments/Updates
7.4.6 Prescient Medicine Holding Competitive Strengths & Weaknesses
7.5 Micronoma
7.5.1 Micronoma Details
7.5.2 Micronoma Major Business
7.5.3 Micronoma Cancer Microbiome Product and Services
7.5.4 Micronoma Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Micronoma Recent Developments/Updates
7.5.6 Micronoma Competitive Strengths & Weaknesses
7.6 Novogene
7.6.1 Novogene Details
7.6.2 Novogene Major Business
7.6.3 Novogene Cancer Microbiome Product and Services
7.6.4 Novogene Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Novogene Recent Developments/Updates
7.6.6 Novogene Competitive Strengths & Weaknesses
7.7 Oxford Nanopore Technologies
7.7.1 Oxford Nanopore Technologies Details
7.7.2 Oxford Nanopore Technologies Major Business
7.7.3 Oxford Nanopore Technologies Cancer Microbiome Product and Services
7.7.4 Oxford Nanopore Technologies Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Oxford Nanopore Technologies Recent Developments/Updates
7.7.6 Oxford Nanopore Technologies Competitive Strengths & Weaknesses
7.8 Pacific Biosciences
7.8.1 Pacific Biosciences Details
7.8.2 Pacific Biosciences Major Business
7.8.3 Pacific Biosciences Cancer Microbiome Product and Services
7.8.4 Pacific Biosciences Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Pacific Biosciences Recent Developments/Updates
7.8.6 Pacific Biosciences Competitive Strengths & Weaknesses
7.9 Qiagen
7.9.1 Qiagen Details
7.9.2 Qiagen Major Business
7.9.3 Qiagen Cancer Microbiome Product and Services
7.9.4 Qiagen Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Qiagen Recent Developments/Updates
7.9.6 Qiagen Competitive Strengths & Weaknesses
7.10 Therma Fisher Scientific
7.10.1 Therma Fisher Scientific Details
7.10.2 Therma Fisher Scientific Major Business
7.10.3 Therma Fisher Scientific Cancer Microbiome Product and Services
7.10.4 Therma Fisher Scientific Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Therma Fisher Scientific Recent Developments/Updates
7.10.6 Therma Fisher Scientific Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Cancer Microbiome Industry Chain
8.2 Cancer Microbiome Upstream Analysis
8.3 Cancer Microbiome Midstream Analysis
8.4 Cancer Microbiome Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Cancer Microbiome Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Cancer Microbiome Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Cancer Microbiome Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Cancer Microbiome Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Cancer Microbiome Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cancer Microbiome Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Cancer Microbiome Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Cancer Microbiome Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Cancer Microbiome Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Cancer Microbiome Players in 2022
Table 12. World Cancer Microbiome Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Cancer Microbiome Company Evaluation Quadrant
Table 14. Head Office of Key Cancer Microbiome Player
Table 15. Cancer Microbiome Market: Company Product Type Footprint
Table 16. Cancer Microbiome Market: Company Product Application Footprint
Table 17. Cancer Microbiome Mergers & Acquisitions Activity
Table 18. United States VS China Cancer Microbiome Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Cancer Microbiome Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Cancer Microbiome Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cancer Microbiome Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Cancer Microbiome Revenue Market Share (2018-2023)
Table 23. China Based Cancer Microbiome Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cancer Microbiome Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Cancer Microbiome Revenue Market Share (2018-2023)
Table 26. Rest of World Based Cancer Microbiome Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Cancer Microbiome Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Cancer Microbiome Revenue Market Share (2018-2023)
Table 29. World Cancer Microbiome Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Cancer Microbiome Market Size by Type (2018-2023) & (USD Million)
Table 31. World Cancer Microbiome Market Size by Type (2024-2029) & (USD Million)
Table 32. World Cancer Microbiome Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Cancer Microbiome Market Size by Application (2018-2023) & (USD Million)
Table 34. World Cancer Microbiome Market Size by Application (2024-2029) & (USD Million)
Table 35. CD Genomics Basic Information, Area Served and Competitors
Table 36. CD Genomics Major Business
Table 37. CD Genomics Cancer Microbiome Product and Services
Table 38. CD Genomics Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. CD Genomics Recent Developments/Updates
Table 40. CD Genomics Competitive Strengths & Weaknesses
Table 41. Eurofins Scientific Basic Information, Area Served and Competitors
Table 42. Eurofins Scientific Major Business
Table 43. Eurofins Scientific Cancer Microbiome Product and Services
Table 44. Eurofins Scientific Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Eurofins Scientific Recent Developments/Updates
Table 46. Eurofins Scientific Competitive Strengths & Weaknesses
Table 47. Illumina Basic Information, Area Served and Competitors
Table 48. Illumina Major Business
Table 49. Illumina Cancer Microbiome Product and Services
Table 50. Illumina Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Illumina Recent Developments/Updates
Table 52. Illumina Competitive Strengths & Weaknesses
Table 53. Prescient Medicine Holding Basic Information, Area Served and Competitors
Table 54. Prescient Medicine Holding Major Business
Table 55. Prescient Medicine Holding Cancer Microbiome Product and Services
Table 56. Prescient Medicine Holding Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Prescient Medicine Holding Recent Developments/Updates
Table 58. Prescient Medicine Holding Competitive Strengths & Weaknesses
Table 59. Micronoma Basic Information, Area Served and Competitors
Table 60. Micronoma Major Business
Table 61. Micronoma Cancer Microbiome Product and Services
Table 62. Micronoma Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Micronoma Recent Developments/Updates
Table 64. Micronoma Competitive Strengths & Weaknesses
Table 65. Novogene Basic Information, Area Served and Competitors
Table 66. Novogene Major Business
Table 67. Novogene Cancer Microbiome Product and Services
Table 68. Novogene Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Novogene Recent Developments/Updates
Table 70. Novogene Competitive Strengths & Weaknesses
Table 71. Oxford Nanopore Technologies Basic Information, Area Served and Competitors
Table 72. Oxford Nanopore Technologies Major Business
Table 73. Oxford Nanopore Technologies Cancer Microbiome Product and Services
Table 74. Oxford Nanopore Technologies Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Oxford Nanopore Technologies Recent Developments/Updates
Table 76. Oxford Nanopore Technologies Competitive Strengths & Weaknesses
Table 77. Pacific Biosciences Basic Information, Area Served and Competitors
Table 78. Pacific Biosciences Major Business
Table 79. Pacific Biosciences Cancer Microbiome Product and Services
Table 80. Pacific Biosciences Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Pacific Biosciences Recent Developments/Updates
Table 82. Pacific Biosciences Competitive Strengths & Weaknesses
Table 83. Qiagen Basic Information, Area Served and Competitors
Table 84. Qiagen Major Business
Table 85. Qiagen Cancer Microbiome Product and Services
Table 86. Qiagen Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Qiagen Recent Developments/Updates
Table 88. Therma Fisher Scientific Basic Information, Area Served and Competitors
Table 89. Therma Fisher Scientific Major Business
Table 90. Therma Fisher Scientific Cancer Microbiome Product and Services
Table 91. Therma Fisher Scientific Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 92. Global Key Players of Cancer Microbiome Upstream (Raw Materials)
Table 93. Cancer Microbiome Typical Customers
Table 1. World Cancer Microbiome Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Cancer Microbiome Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Cancer Microbiome Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Cancer Microbiome Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Cancer Microbiome Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cancer Microbiome Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Cancer Microbiome Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Cancer Microbiome Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Cancer Microbiome Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Cancer Microbiome Players in 2022
Table 12. World Cancer Microbiome Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Cancer Microbiome Company Evaluation Quadrant
Table 14. Head Office of Key Cancer Microbiome Player
Table 15. Cancer Microbiome Market: Company Product Type Footprint
Table 16. Cancer Microbiome Market: Company Product Application Footprint
Table 17. Cancer Microbiome Mergers & Acquisitions Activity
Table 18. United States VS China Cancer Microbiome Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Cancer Microbiome Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Cancer Microbiome Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cancer Microbiome Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Cancer Microbiome Revenue Market Share (2018-2023)
Table 23. China Based Cancer Microbiome Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cancer Microbiome Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Cancer Microbiome Revenue Market Share (2018-2023)
Table 26. Rest of World Based Cancer Microbiome Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Cancer Microbiome Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Cancer Microbiome Revenue Market Share (2018-2023)
Table 29. World Cancer Microbiome Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Cancer Microbiome Market Size by Type (2018-2023) & (USD Million)
Table 31. World Cancer Microbiome Market Size by Type (2024-2029) & (USD Million)
Table 32. World Cancer Microbiome Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Cancer Microbiome Market Size by Application (2018-2023) & (USD Million)
Table 34. World Cancer Microbiome Market Size by Application (2024-2029) & (USD Million)
Table 35. CD Genomics Basic Information, Area Served and Competitors
Table 36. CD Genomics Major Business
Table 37. CD Genomics Cancer Microbiome Product and Services
Table 38. CD Genomics Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. CD Genomics Recent Developments/Updates
Table 40. CD Genomics Competitive Strengths & Weaknesses
Table 41. Eurofins Scientific Basic Information, Area Served and Competitors
Table 42. Eurofins Scientific Major Business
Table 43. Eurofins Scientific Cancer Microbiome Product and Services
Table 44. Eurofins Scientific Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Eurofins Scientific Recent Developments/Updates
Table 46. Eurofins Scientific Competitive Strengths & Weaknesses
Table 47. Illumina Basic Information, Area Served and Competitors
Table 48. Illumina Major Business
Table 49. Illumina Cancer Microbiome Product and Services
Table 50. Illumina Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Illumina Recent Developments/Updates
Table 52. Illumina Competitive Strengths & Weaknesses
Table 53. Prescient Medicine Holding Basic Information, Area Served and Competitors
Table 54. Prescient Medicine Holding Major Business
Table 55. Prescient Medicine Holding Cancer Microbiome Product and Services
Table 56. Prescient Medicine Holding Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Prescient Medicine Holding Recent Developments/Updates
Table 58. Prescient Medicine Holding Competitive Strengths & Weaknesses
Table 59. Micronoma Basic Information, Area Served and Competitors
Table 60. Micronoma Major Business
Table 61. Micronoma Cancer Microbiome Product and Services
Table 62. Micronoma Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Micronoma Recent Developments/Updates
Table 64. Micronoma Competitive Strengths & Weaknesses
Table 65. Novogene Basic Information, Area Served and Competitors
Table 66. Novogene Major Business
Table 67. Novogene Cancer Microbiome Product and Services
Table 68. Novogene Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Novogene Recent Developments/Updates
Table 70. Novogene Competitive Strengths & Weaknesses
Table 71. Oxford Nanopore Technologies Basic Information, Area Served and Competitors
Table 72. Oxford Nanopore Technologies Major Business
Table 73. Oxford Nanopore Technologies Cancer Microbiome Product and Services
Table 74. Oxford Nanopore Technologies Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Oxford Nanopore Technologies Recent Developments/Updates
Table 76. Oxford Nanopore Technologies Competitive Strengths & Weaknesses
Table 77. Pacific Biosciences Basic Information, Area Served and Competitors
Table 78. Pacific Biosciences Major Business
Table 79. Pacific Biosciences Cancer Microbiome Product and Services
Table 80. Pacific Biosciences Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Pacific Biosciences Recent Developments/Updates
Table 82. Pacific Biosciences Competitive Strengths & Weaknesses
Table 83. Qiagen Basic Information, Area Served and Competitors
Table 84. Qiagen Major Business
Table 85. Qiagen Cancer Microbiome Product and Services
Table 86. Qiagen Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Qiagen Recent Developments/Updates
Table 88. Therma Fisher Scientific Basic Information, Area Served and Competitors
Table 89. Therma Fisher Scientific Major Business
Table 90. Therma Fisher Scientific Cancer Microbiome Product and Services
Table 91. Therma Fisher Scientific Cancer Microbiome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 92. Global Key Players of Cancer Microbiome Upstream (Raw Materials)
Table 93. Cancer Microbiome Typical Customers
LIST OF FIGURES
Figure 1. Cancer Microbiome Picture
Figure 2. World Cancer Microbiome Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Cancer Microbiome Total Market Size (2018-2029) & (USD Million)
Figure 4. World Cancer Microbiome Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Cancer Microbiome Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Cancer Microbiome Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Cancer Microbiome Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Cancer Microbiome Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Cancer Microbiome Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Cancer Microbiome Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Cancer Microbiome Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Cancer Microbiome Revenue (2018-2029) & (USD Million)
Figure 13. Cancer Microbiome Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cancer Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 16. World Cancer Microbiome Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Cancer Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 18. China Cancer Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Cancer Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Cancer Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Cancer Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Cancer Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 23. India Cancer Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Cancer Microbiome by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cancer Microbiome Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cancer Microbiome Markets in 2022
Figure 27. United States VS China: Cancer Microbiome Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Cancer Microbiome Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Cancer Microbiome Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Cancer Microbiome Market Size Market Share by Type in 2022
Figure 31. Next Generation Sequencing
Figure 32. Polymerase Chain Reaction
Figure 33. World Cancer Microbiome Market Size Market Share by Type (2018-2029)
Figure 34. World Cancer Microbiome Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Cancer Microbiome Market Size Market Share by Application in 2022
Figure 36. Hospitals
Figure 37. Clinic
Figure 38. Others
Figure 39. Cancer Microbiome Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Figure 1. Cancer Microbiome Picture
Figure 2. World Cancer Microbiome Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Cancer Microbiome Total Market Size (2018-2029) & (USD Million)
Figure 4. World Cancer Microbiome Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Cancer Microbiome Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Cancer Microbiome Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Cancer Microbiome Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Cancer Microbiome Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Cancer Microbiome Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Cancer Microbiome Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Cancer Microbiome Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Cancer Microbiome Revenue (2018-2029) & (USD Million)
Figure 13. Cancer Microbiome Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cancer Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 16. World Cancer Microbiome Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Cancer Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 18. China Cancer Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Cancer Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Cancer Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Cancer Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Cancer Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 23. India Cancer Microbiome Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Cancer Microbiome by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cancer Microbiome Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cancer Microbiome Markets in 2022
Figure 27. United States VS China: Cancer Microbiome Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Cancer Microbiome Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Cancer Microbiome Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Cancer Microbiome Market Size Market Share by Type in 2022
Figure 31. Next Generation Sequencing
Figure 32. Polymerase Chain Reaction
Figure 33. World Cancer Microbiome Market Size Market Share by Type (2018-2029)
Figure 34. World Cancer Microbiome Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Cancer Microbiome Market Size Market Share by Application in 2022
Figure 36. Hospitals
Figure 37. Clinic
Figure 38. Others
Figure 39. Cancer Microbiome Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
